A detailed history of Warner Financial, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Warner Financial, Inc holds 490 shares of LLY stock, worth $434,605. This represents 0.22% of its overall portfolio holdings.

Number of Shares
490
Previous 984 50.2%
Holding current value
$434,605
Previous $766,000 42.04%
% of portfolio
0.22%
Previous 0.38%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $358,085 - $449,065
-494 Reduced 50.2%
490 $444,000
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $582,132 - $778,811
-983 Reduced 49.97%
984 $766,000
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $1.03 Million - $1.22 Million
1,967 New
1,967 $1.15 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Warner Financial, Inc Portfolio

Follow Warner Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warner Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Warner Financial, Inc with notifications on news.